Patent Assignment
Reel/Frame 055355/0229
Assignment of Assignor's Interest
Recorded: 2021-02-22
Pages: 6
Assignor
REGENERON PHARMACEUTICALS, INC.
Executed: 2020-12-10
Assignees
INTELLIA THERAPEUTICS, INC.
40 ERIE STREET, SUITE 130, CAMBRIDGE, MASSACHUSETTS, 02139
REGENERON PHARMACEUTICALS, INC.
777 OLD SAW MILL RIVER RD, TARRYTOWN, NEW YORK, 10591
Covered Property
(1)
Compositions and Methods for Expressing Factor Ix
Patent:
12,214,023 →
Application:
16/657,961 →
Publication:
US 2020/0289628
PCT:
PCT/US2019/057090 ↗
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 17, 2021
From: FINN, JONATHAN DOUGLAS; HUANG, HON-REN; ROY, MOITRI
To: INTELLIA THERAPEUTICS, INC.
Reel/Frame 055296/0591 →
Assignment of Assignor's Interest
Feb 17, 2021
From: LAI, KEHDIH; SATTLER, RACHEL; KYRATSOUS, CHRISTOS; WANG, CHENG
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 055296/0773 →
Assignment of Assignor's Interest
Feb 17, 2021
From: INTELLIA THERAPEUTICS, INC.
To: INTELLIA THERAPEUTICS, INC.; REGENERON PHARMACEUTICALS, INC.
Reel/Frame 055319/0974 →